FIELD: biotechnology; medicine.
SUBSTANCE: present invention relates to biotechnology and can be used in medicine. There are disclosed capsular saccharide glycoconjugates obtained from bacteria Streptococcus pneumoniae serotype 3, in which the bacterial antigen is attached to a carrier protein through a short linker sequence using click-chemistry.
EFFECT: invention can be used to treat or alleviate an infection of Streptococcus pneumoniae or a disease or condition caused by it.
23 cl, 11 ex, 15 tbl, 8 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| IMMUNOGENIC COMPOSITIONS FOR USE IN PNEUMOCOCCAL VACCINES | 2021 |
|
RU2827429C1 |
| IMMUNOGENIC COMPOSITIONS CONTAINING CONJUGATED CAPSULAR SACCHARIDE ANTIGENS AND APPLICATION THEREOF | 2021 |
|
RU2774075C1 |
| IMMUNOGENIC COMPOSITIONS CONTAINING CONJUGATED CAPSULE SACCHARIDE ANTIGENS AND THEIR USE | 2015 |
|
RU2771293C2 |
| IMMUNOGENIC COMPOSITIONS CONTAINING CONJUGATED CAPSULAR SACCHARIDE ANTIGENS AND USE THEREOF | 2015 |
|
RU2778704C2 |
| IMMUNOGENIC COMPOSITIONS CONTAINING CONJUGATED CAPSULAR SACCHARIDE ANTIGENS AND USE THEREOF | 2015 |
|
RU2687460C2 |
| PNEUMOCOCCAL POLYSACCHARIDES AND THEIR USE IN POLYSACCHARIDE-PROTEIN-CARRIER IMMUNOGENIC CONJUGATES | 2018 |
|
RU2801288C2 |
| IMMUNOGENIC COMPOSITIONS FOR USE IN PNEUMOCOCCAL VACCINES | 2018 |
|
RU2762723C2 |
| PNEUMOCOCCAL POLYSACCHARIDES AND THEIR USE IN IMMUNOGENIC POLYSACCHARIDE-PROTEIN-CARRIER CONJUGATES | 2018 |
|
RU2784449C2 |
| PNEUMOCOCCAL POLYSACCHARIDES AND THEIR USE IN IMMUNOGEN POLYSACCHARIDE-PROTEIN-CARRIER CONJUGATES | 2018 |
|
RU2785429C2 |
| PNEUMOCOCCAL POLYSACCHARIDES AND THEIR USE IN POLYSACCHARIDE-PROTEIN-CARRIER IMMUNOGENIC CONJUGATES | 2018 |
|
RU2801304C2 |
